NT-proBNP as a Biomarker of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation
Authors:
- Kimberly UchidaKUKimberly Uchida
- Xiaomeng YuanXYXiaomeng Yuan
- Jennifer McArthurJennifer McArthur
- Rebekah LassiterRLRebekah Lassiter
- Haitao PanHPHaitao Pan
- Dinesh KeerthiDKDinesh Keerthi
- Katherine TsaiKTKatherine Tsai
- Yvonne AventYAYvonne Avent
- Melissa HinesMHMelissa Hines
- Hugo R. MartinezHugo R. Martinez
- Amr QudeimatAQAmr Qudeimat
- Saad GhafoorSGSaad Ghafoor
Preprint
- 26 August 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: Hematopoietic stem cell transplantation (HSCT) in pediatric and young adult (YA) patients can lead to endotheliopathy, such as thrombotic microangiopathy (TMA), sinusoidal obstruction syndrome (SOS), and diffuse alveolar hemorrhage (DAH). Natriuretic peptides have been studied as markers of endotheliopathy and critical illness. We hypothesized that elevation in NT-proBNP was associated with development of endotheliopathy (DAH, SOS, or TMA) in the first 100 days following HSCT in pediatric and YA patients. Methods: IRB exempt status was obtained. This retrospective case-control study reviewed HSCT at our institution from 2016-2020. Cases were selected based on an endotheliopathy diagnosis in the first 100 days after HSCT. Cases were matched with controls. Baseline and near-event NT-proBNP levels were compared between cases and matched controls. Effect of NT-proBNP levels on developing endotheliopathy was estimated using conditional logistic regression. Results: Sixty-two patients were included (31 cases, 31 controls). Near-event NT-proBNP was significantly higher in cases compared to controls (Median: 473 vs. 187 pg/mL, p = 0.03, Wilcoxon rank-sum test), in contrast to comparison in baseline NT-proBNP (Median: 86 vs. 86 pg/mL, p = 0.51). After adjusting for co-variates, association between near-event NT-proBNP and odds of developing endotheliopathy did not achieve statistical significance. However, trends from most common transplant indications suggested an association between elevated near-event NT-proBNP level and endotheliopathy, particularly in acute lymphoblastic leukemia (ALL) patients. Conclusions: NT-proBNP should be studied further as a biomarker for endotheliopathy in pediatric and YA patients undergoing HSCT. This may be particularly relevant for patients undergoing HSCT for ALL.Keywords
All Related Versions
- Version 1, 2024-08-26, Preprints
- Published version: Pediatric Reports, 16 (4), 934.
This publication has 31 references indexed in Scilit:
- Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortalityPediatric Blood & Cancer, 2021
- Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplantPediatric Blood & Cancer, 2017
- Can We Predict Clinical Cardiotoxicity with Cardiac Biomarkers in Patients After Haematopoietic Stem Cell Transplantation?Cardiovascular Toxicology, 2014
- The role of the endothelium in the short-term complications of hematopoietic SCTBone Marrow Transplantation, 2011
- Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2010
- Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular DiseasesAmerican Journal of Hypertension, 2008
- The Contribution of Endothelial Activation and Injury to End-Organ Toxicity following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2008
- NT-ProBNP: The Mechanism Behind the MarkerJournal of Cardiac Failure, 2005
- Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinaseJournal of Molecular and Cellular Cardiology, 2004
- Early and late elevation of plasma atrial and brain natriuretic peptides in patients after bone marrow transplantationAnnals of Hematology, 2001